Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.
Researchers supported by the National Institutes of Health have discovered that black and white patients with advanced glaucoma respond differently to two surgical treatments for the disease. A paper detailing these findings is published in the July 1998
Researchers found that patients with large eye melanomas had similar five-year survival rates regardless of whether they were treated with radiation prior to removal of the eye or had their eye removed without prior radiation therapy.
Researchers supported by the National Eye Institute have determined that light reduction has no effect on the development of a potentially blinding eye disorder in low birthweight infants
Researchers at the National Institutes of Health (NIH) have discovered a substance that allows people with uveitis, a potentially blinding eye disease, to stop or reduce the need for powerful drugs.
Researchers at the National Institutes of Health have discovered that a combination of protease inhibitors and other anti-HIV drugs used to treat people with AIDS
The Senate Appropriations Committee, in its report accompanying the fiscal year 1997 Appropriations Bill, has requested a report from the National Eye Institute (NEI).
Researchers have stopped patient enrollment and treatment in a study designed to evaluate the safety and effectiveness of a new drug to treat a blinding eye infection common in people with AIDS.
Follow-up results from a study of premature babies with a potentially blinding condition confirm that a freezing treatment applied to their eyes helps save their sight.
A combination of two antiviral drugs is more effective than either drug alone for controlling recurrences of a blinding eye infection common in people with AIDS, according to new clinical trial results from a federally-sponsored study.
Laser therapy is a safe and effective alternative to eyedrops as afirst-line treatment for patients with newly diagnosed primaryopen-angle glaucoma, according to research results released today.